Pui–Chee Wu
Impact in
- Epidemiology top 0.5%
- Hepatitis B Virus Studies
- Fungal Infections and Studies
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver physiology and pathology
- Liver Disease and Transplantation
Papers in
- Epidemiology 13
- Hepatitis B Virus Studies 12
- Fungal Infections and Studies 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Hepatitis C virus research 2
- Co-authors
- Ching‐Lung Lai (21 shared papers)Anna Suk-Fong Lok (10 shared papers)Richard Guan (1 shared paper)D. Fraser Gray (1 shared paper)Nancy W.Y. Leung (1 shared paper)Julie C. Dent (1 shared paper)Rong‐Nan Chien (1 shared paper)Ting‐Tsung Chang (1 shared paper)
- Journals
- Gastroenterology (3 papers)Cancer (3 papers)The Lancet (2 papers)American Journal of Clinical Pathology (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
Pui–Chee Wu
27 papers receiving 3.3k citations
Pui–Chee Wu's Hit Papers
Peers
Comparison fields: 5 of 67
- Epidemiology 2.2k
- Hepatology 581
- Pharmacology 131
- Infectious Diseases 43
- Biological Psychiatry 2
Countries citing papers authored by Pui–Chee Wu
This map shows the geographic impact of Pui–Chee Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pui–Chee Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pui–Chee Wu more than expected).
Fields of papers citing papers by Pui–Chee Wu
This network shows the impact of papers produced by Pui–Chee Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pui–Chee Wu. The network helps show where Pui–Chee Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pui–Chee Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A One-Year Trial of Lamivudine for Chronic Hepatitis B Hit paper breakdown → | 1998 | 1510 |
| 2 | 1988 | 311 | |
| 3 | 1987 | 270 | |
| 4 | 1992 | 211 | |
| 5 | 2000 | 195 | |
| 6 | 1993 | 193 | |
| 7 | 1988 | 156 | |
| 8 | 2001 | 127 | |
| 9 | 1987 | 124 | |
| 10 | 1998 | 69 | |
| 11 | 1985 | 51 | |
| 12 | 1983 | 38 | |
| 13 | 1987 | 27 | |
| 14 | 1994 | 23 | |
| 15 | 1996 | 23 | |
| 16 | 1986 | 22 | |
| 17 | 1985 | 21 | |
| 18 | 1989 | 16 | |
| 19 | 1993 | 16 | |
| 20 | 1987 | 15 |
About Pui–Chee Wu
Pui–Chee Wu is a scholar working on Epidemiology, Hepatology, Oral Surgery, Pharmacology and Oncology, having authored 27 papers that have together received 3.5k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Hepatitis C virus research (2 papers), Porphyrin Metabolism and Disorders (1 paper), Plant Toxicity and Pharmacological Properties (1 paper), Fungal Infections and Studies (1 paper), Oral and Maxillofacial Pathology (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Epidemiology (2.2k citations), Hepatology (581 citations), Pharmacology (131 citations), Infectious Diseases (43 citations) and Biological Psychiatry (2 citations). Pui–Chee Wu has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Ching‐Lung Lai, Anna Suk-Fong Lok, Richard Guan, D. Fraser Gray, Nancy W.Y. Leung, Julie C. Dent, Rong‐Nan Chien, Ting‐Tsung Chang, Dar‐In Tai and Keng–Yeen Ng. Their work appears in journals such as Gastroenterology, Cancer, The Lancet, American Journal of Clinical Pathology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.